Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress

Oncology; Pharmacology & Pharmaceuticals

Address: Rome, Rome, Italy
Date: 17 to 19 Oct '19
Price: Under 500 USD$
Time: 9:00am to 6:00pm (GMT+01:00) Amsterdam, Berlin, Bern, Rome, Stockholm, Vienna
Visit Event Website

Global Experts Meeting on Frontiers in
Biosimilars and Biologics Congress
Theme: The future of next generation Biosimilars and Biologics

Frontiers Meetings takes pleasure in inviting the scientific community across the globe to attend the Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress during October 17-19, 2019 at Rome, Italy with a motto to Explore Innovations in Biosimilars & Biologics.

This Biosimilars 2019 Conference will bring together Professors, scientists, researchers, business development managers, CEOs, directors, IP Attorneys, Regulatory Officials, CROs and students from around the world. The passage of biosimilars through a decade at Europe finds much requirement for discussion also focussing the latest developments in the field of biologics and Biosimilars.

Biosimilars 2019 Conference will encourage Young Researcher’s Forum, scientists and the researchers in their early stage of career graph to widely discuss their outcome so as to enrich and develop the idea. Rewards for the Best Oral and Poster Presentation is meant to encourage students in taking active part in the International Science platform to sharpen their skills and knowledgebase.

Biosimilars 2019 is comprised of 16 tracks and 90 sessions designed to offer comprehensive sessions that address current issue. For more scientific sessions and abstract submission, please visit:

Grab the opportunity to participate by registering through flowing link:

For further details, please contact:
Jon Peters | Program Director
Program Manager | Biosimilar Conferences
London, England, UK


Key Themes & Topics

The important tracks that are part of Biosimilars 2019 includes:

1. Challenges in Biosimilars and Biologics Development
2. Biosimilars Analytical Strategies
3. Formulation Strategies for Follow-on Biologics
4. BPCIA and Regulatory Updates
5. Intellectual Property Rights for Biosimilars
6. Biologics as therapeutics
7. Emerging Biosimilars and research pipelines
8. Monoclonal Antibody Biosimilars
9. BCS and IVIVC Based Biowaivers
10. Biogenerics and Biopharmaceuticals
11. Biosimilars Clinical Research and Pharmacovigilance
12. Clinicians Approach for Biosimilars
13. Globalization of Biosimilars
14. Biosimilars Market and Cost Analysis
15. Globalization of Biosimilars
16. Brexit Conundrums on Biosimilars

Who Should Attend

- CSOs, CMOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, and Senior Scientists of pharma companies
- Pharmaceutical science Associations, Societies and Universities
- Biopharmaceutical R&D scientists
- Drug development researchers
- Drug delivery researchers
- Biotechnology Research scientists
- IP attorneys and Law firms
- Patent examiners


Get the latest updates




Get the latest updates





Frontiers Meetings Ltd

Share with your network

 Please check the official event website for possible changes before you make any travel arrangements.
Prices are for evaluation only.